{
  "trial_id": "NCT02662569",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, baseline LDL-C levels, baseline HDL-C levels, baseline triglyceride levels, baseline total cholesterol levels, body mass index (BMI), blood pressure, HbA1c levels, use of lipid-lowering therapy, use of antihypertensive therapy, smoking status, history of cardiovascular disease, baseline fasting glucose levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Low-density Lipoprotein Cholesterol (LDL-C) Concentration",
          "baseline LDL-C levels"
        ],
        [
          "High-density Lipoprotein Cholesterol (HDL-C) Concentration",
          "baseline HDL-C levels"
        ],
        [
          "Triglycerides Concentration",
          "baseline triglyceride levels"
        ],
        [
          "Total Cholesterol",
          "baseline total cholesterol levels"
        ],
        [
          "Stratification Factor: Statin Therapy at Study Entry",
          "use of lipid-lowering therapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Stratification Factor: Geographic Region",
        "Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration",
        "Apolipoprotein B100 Concentration",
        "Total Cholesterol/High-density Lipoprotein Cholesterol(HDL-C) Ratio",
        "Apolipoprotein B100/Apolipoprotein A1 Ratio",
        "Lipoprotein (a)",
        "Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "body mass index (BMI)",
        "blood pressure",
        "HbA1c levels",
        "use of antihypertensive therapy",
        "smoking status",
        "history of cardiovascular disease",
        "baseline fasting glucose levels"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline LDL-C, Baseline HbA1c, Body Mass Index, Blood Pressure, Use of Lipid-lowering Therapy, Use of Statin Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Stratification Factor: Statin Therapy at Study Entry",
          "Use of Statin Therapy"
        ],
        [
          "Low-density Lipoprotein Cholesterol (LDL-C) Concentration",
          "Baseline LDL-C"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Stratification Factor: Geographic Region",
        "Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration",
        "Apolipoprotein B100 Concentration",
        "Total Cholesterol",
        "Total Cholesterol/High-density Lipoprotein Cholesterol(HDL-C) Ratio",
        "Apolipoprotein B100/Apolipoprotein A1 Ratio",
        "Lipoprotein (a)",
        "Triglycerides Concentration",
        "High-density Lipoprotein Cholesterol (HDL-C) Concentration",
        "Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Duration of Diabetes",
        "Baseline HbA1c",
        "Body Mass Index",
        "Blood Pressure",
        "Use of Lipid-lowering Therapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes duration, HbA1c, LDL-C, HDL-C, Triglycerides, Statin therapy, Blood pressure, BMI, Waist circumference, History of cardiovascular disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Stratification Factor: Statin Therapy at Study Entry",
          "Statin therapy"
        ],
        [
          "Low-density Lipoprotein Cholesterol (LDL-C) Concentration",
          "LDL-C"
        ],
        [
          "High-density Lipoprotein Cholesterol (HDL-C) Concentration",
          "HDL-C"
        ],
        [
          "Triglycerides Concentration",
          "Triglycerides"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Stratification Factor: Geographic Region",
        "Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration",
        "Apolipoprotein B100 Concentration",
        "Total Cholesterol",
        "Total Cholesterol/High-density Lipoprotein Cholesterol(HDL-C) Ratio",
        "Apolipoprotein B100/Apolipoprotein A1 Ratio",
        "Lipoprotein (a)",
        "Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes duration",
        "HbA1c",
        "Blood pressure",
        "BMI",
        "Waist circumference",
        "History of cardiovascular disease."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, type of diabetes treatment, duration of statin therapy, LDL-C at screening, fasting glucose, hemoglobin A1c (HbA1c), systolic blood pressure, diastolic blood pressure, heart rate, medical history of cardiovascular disease, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Stratification Factor: Statin Therapy at Study Entry",
          "duration of statin therapy"
        ],
        [
          "Low-density Lipoprotein Cholesterol (LDL-C) Concentration",
          "LDL-C at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Stratification Factor: Geographic Region",
        "Non-high-density Lipoprotein Cholesterol (non-HDL-C) Concentration",
        "Apolipoprotein B100 Concentration",
        "Total Cholesterol",
        "Total Cholesterol/High-density Lipoprotein Cholesterol(HDL-C) Ratio",
        "Apolipoprotein B100/Apolipoprotein A1 Ratio",
        "Lipoprotein (a)",
        "Triglycerides Concentration",
        "High-density Lipoprotein Cholesterol (HDL-C) Concentration",
        "Very Low-density Lipoprotein Cholesterol (VLDL-C) Concentration"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of diabetes",
        "type of diabetes treatment",
        "fasting glucose",
        "hemoglobin A1c (HbA1c)",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "medical history of cardiovascular disease",
        "smoking status"
      ]
    }
  }
}